ATE301194T1 - Beta-defensine - Google Patents

Beta-defensine

Info

Publication number
ATE301194T1
ATE301194T1 AT98947034T AT98947034T ATE301194T1 AT E301194 T1 ATE301194 T1 AT E301194T1 AT 98947034 T AT98947034 T AT 98947034T AT 98947034 T AT98947034 T AT 98947034T AT E301194 T1 ATE301194 T1 AT E301194T1
Authority
AT
Austria
Prior art keywords
beta
defensine
zampl
polypeptides
present
Prior art date
Application number
AT98947034T
Other languages
English (en)
Inventor
David Adler
James L Holloway
Nand Baindur
Stephanie Beigel
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE301194T1 publication Critical patent/ATE301194T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Gyroscopes (AREA)
  • Silicon Polymers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Photoreceptors In Electrophotography (AREA)
AT98947034T 1997-09-10 1998-09-10 Beta-defensine ATE301194T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5833597P 1997-09-10 1997-09-10
US92652997A 1997-09-10 1997-09-10
US6429497P 1997-11-05 1997-11-05
US96468797A 1997-11-05 1997-11-05
PCT/US1998/019222 WO1999013080A1 (en) 1997-09-10 1998-09-10 Beta-defensins

Publications (1)

Publication Number Publication Date
ATE301194T1 true ATE301194T1 (de) 2005-08-15

Family

ID=27489968

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98947034T ATE301194T1 (de) 1997-09-10 1998-09-10 Beta-defensine

Country Status (8)

Country Link
EP (1) EP1012285B1 (de)
JP (1) JP2001515720A (de)
AT (1) ATE301194T1 (de)
AU (1) AU744152B2 (de)
CA (1) CA2303421C (de)
DE (1) DE69831084T2 (de)
DK (1) DK1012285T3 (de)
WO (1) WO1999013080A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000046245A2 (de) * 1999-02-01 2000-08-10 Schering Aktiengesellschaft Humane antibiotische proteine
US6335318B1 (en) 1999-05-10 2002-01-01 The Regents Of The University Of California Antimicrobial theta defensins and methods of using same
CA2389256A1 (en) * 1999-10-28 2001-05-03 Zymogenetics, Inc. Beta-defensins
DE19957043A1 (de) * 1999-11-26 2001-06-07 Forssmann Wolf Georg Neue Defensine
US6809181B2 (en) * 2000-06-01 2004-10-26 University Of Iowa Research Foundation Human beta-defensin-3 (HBD-3), a highly cationic beta-defensin antimicrobial peptide
AU2001289641A1 (en) * 2000-07-11 2002-01-21 Ipf Pharmaceuticals Gmbh Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses
AU2002227925A1 (en) * 2000-11-14 2002-05-27 Ipf Pharmaceuticals Gmbh Human beta-defensin-3
US7119070B2 (en) 2002-04-30 2006-10-10 The Regents Of The University Of California Antimicrobial theta defensins, analogs thereof, and methods of use
GB0223655D0 (en) * 2002-10-10 2002-11-20 Mabtech Ab Method of diagnosis
FR2879203A1 (fr) * 2004-12-09 2006-06-16 Univ Rennes I Etablissement Pu Peptides antimicrobiens, polypeptides comprenant lesdits peptides, procedes pour les preparer, genes codant pour lesdits peptides, vecteurs, organismes transformes et compositions les contenant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550109A (en) * 1994-05-24 1996-08-27 Magainin Pharmaceuticals Inc. Inducible defensin peptide from mammalian epithelia
EP1367124A1 (de) * 1997-08-01 2003-12-03 Genset 5' Ests für sekretierte Proteine, die im Muskel und anderen mesodermalen Geweben exprimiert werden

Also Published As

Publication number Publication date
EP1012285B1 (de) 2005-08-03
EP1012285A1 (de) 2000-06-28
DE69831084D1 (de) 2005-09-08
JP2001515720A (ja) 2001-09-25
DK1012285T3 (da) 2005-12-12
AU744152B2 (en) 2002-02-14
CA2303421C (en) 2005-07-12
DE69831084T2 (de) 2006-06-01
AU9391598A (en) 1999-03-29
WO1999013080A1 (en) 1999-03-18
CA2303421A1 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
ATE476495T1 (de) Bazillus thuringiensis und dessen insektizide proteine
NO20000934L (no) Adipocyttspesifikke proteinhomologer
DE69131249D1 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
BR0011838B1 (pt) elemento de sela e estrutura de misturador estático.
DE69428238D1 (de) Xylanase von einer Bacillus Spezies, Expressionsvektoren für diese Xylanase und andere Proteine, Wirtsorganismus dafür und Verwendungen davon
DK1002075T3 (da) Adipocyt-specifikke proteinhomologer
DE69434384D1 (de) Metalkomplexbildner
ATE301194T1 (de) Beta-defensine
DE3853748D1 (de) Polypeptide mit aktivität gegen gram-positive und gram-negative bakterien.
DK1169340T3 (da) Lantibiotikum
DE60025026D1 (de) Antimicrobielle wirkung des ersten kationischen cluster des menschlichen lactoferrins
DE69009807D1 (de) Breitband-Schaltmatrix für Verzögerungsausgleich und Inversionseliminierung.
NZ333456A (en) Type-2 chemokine binding proteins and methods of use therefor
ATE301712T1 (de) Z2-19a, ein menschliches homolog von dem protein 2-19
ATE550345T1 (de) Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
ES2142840T3 (es) Proteina que se une al interferon alfa/beta, su preparacion y las composiciones farmaceuticas que la contienen.
FI943218A7 (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja k äytöt
PT676413E (pt) Proteina de ligacao a interferoes alfa/beta, sua preparacao e utilizacao
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe
WO2000073446A3 (en) Adipocyte complement related protein homolog zacrp6
DE69836226D1 (de) Ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone
DE69019581D1 (de) Polypeptid und dieses enthaltende antibaktierelle Präparate.
BR0012740A (pt) Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego
DK0999849T3 (da) Anvendelse af LBP til sepsisbehandling

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1012285

Country of ref document: EP

REN Ceased due to non-payment of the annual fee